Gem Aromatics IPO GMP Today Signals 8% Upside; Subscribed 235% So Far; Worth Investing?

The Gem Aromatics IPO is attracting strong interest across the investor base in the market currently, with healthy subscription numbers and positive activity in the grey market on the second day of bidding. The IPO had been subscribed 2.35 times at the end of 20th August, and the Gem Aromatics IPO GMP is hinting at a potential listing gain of around 8%.

Gem Aromatics IPO Details

Gem Aromatics IPO is valued at Rs. 451.25 crore, and the issue is a book-built type which includes both a fresh issue and an offer for sale.

The IPO opened for subscription yesterday on August 19th and will close on August 21st. The allotment is expected on August 22, with the tentative listing date on August 26, 2025, on both BSE and NSE.

Subscription Status

By Day 2, August 20, the Gem Aromatics IPO was subscribed 2.35 times overall. Looking at the category-wise details, retail investors subscribed 2.71 times, while the QIBs and NIIs held their bids 1.32 times and 2.87 times, respectively.

Grey Market Premium and Expected Listing Gains

The Gem Aromatics IPO GMP currently stands at Rs. 26 as of Aug 20, 2025, 1:00 PM, according to the Investorgain website. It is anticipated that an investor who secured the share of IPO would enjoy an 8% listing gain, as the potential listing price is expected to be Rs. 351, adding the Rs. 26 premium.

Should You Apply or Skip?

The IPO has seen encouraging demand and a steady GMP, signalling moderate listing gains. While the 8% premium may not be extremely high, the subscription shows strong investor interest.

Gem Aromatics IPO Analysis by Brokers and Analysts

The Gem Aromatics IPO has received a largely positive response from brokers and market analysts. Leading firms like Anand Rathi, Arihant Capital Markets, BP Equities, Canara Bank Securities, Master Capital, SBICAP Securities, SMIFS, and Ventura Securities have recommended investors to "Apply" in the issue.

Arihant Capital in its review noted that "Gem Aromatics Ltd has a well-diversified product portfolio across mint, clove, phenol and other speciality ingredients supported by an in-house R&D team and advanced technologies that enable innovation and higher-margin value-added derivatives. At the upper band of INR 325, the issue is valued at a P/E ratio of 31.8x, based on annualised PAT of FY25 earnings per share of Rs. 10.2. We are recommending a "Subscribe for Long Term" rating for this issue."

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.